Australian Pharmaceutical Industries Acquisition

Wesfarmers acquired Australian Pharmaceutical Industries Limited (API) on 31 March 2022 by way of a scheme of arrangement. As a result, API shares were suspended from close of trading on the ASX on 22 March 2022 and it was delisted from the ASX on 1 April 2022. API is part of the Health division of Wesfarmers and further information on these businesses can be found here

View copy of API Scheme Booklet

View ATO Class Ruling


API historical shareholding details
You can view your historical API shareholding details online through the former API Share Registry website for Boardroom.

Access your API shareholding details online via InvestorServe or contact Boardroom at the contact points listed below.

API Share Registry
Boardroom Pty Limited
Grosvenor Place
Level 12, 225 George Street
Sydney NSW 2000


GPO Box 3993
Sydney NSW 2001

Phone: 1300 737 760 (within Australia)
Phone: +61 2 9290 9600 (Internationally)
Fax: +61 2 9290 9655